Complex cancer gene therapy in mice melanoma

Langenbeck's Archives of Surgery

Volumn 387, Issue 3-4, 2002, Pages 177-182

  Dietrich, Arne ^a   Kraus, Katja ^a   Brinckmann, Ute ^b   Friedrich, Thomas ^a   Müller, Anke ^b   Liebert, Uwe G ^b   Schönfelder, Manfred ^a  

^a Clin Thoracic Gen/Oncol Surg   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

APC engineering; Cancer; Cytokine; Gene therapy; Melanoma

Indexed keywords

B7 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BIOENGINEERING; CONTROLLED STUDY; FEMALE; GENE GUN; GENE THERAPY; IMMUNOSTIMULATION; INFLAMMATORY CELL; MALE; MELANOMA; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR GROWTH;

ANIMALS; ANTIGENS, CD80; BIOLISTICS; DISEASE MODELS, ANIMAL; FEMALE; GENE THERAPY; GENES, APC; GENETIC ENGINEERING; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-2; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036944154     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-002-0299-5     Document Type: Article

References (25)

1. Yang NS, DeLuna C, Cheng L (1994) In: Wolff JA (ed) Gene therapeutics: methods and applications of direct gene transfer. Birkhäuser, Boston, pp 193-209
2. Rakhmilevich AL, Timmins JG, Jannssen K, Pohlmann EL, Sheehy MJ, Yang NS (1999) Gene gun-mediated IL-12 gene therapy induces antitumor effects in the absence of toxicity: a direct comparison with systemic IL-12 protein therapy. J Immunother 22:135-144
3. Sun WH, Burkholder J, Sun J, Clup J, Turner J, Lu XG, Pugh TD, Ershler WB, Yang NS (1995) In vivo cytokine gene transfer by gene gun reduces tumor growth in mice. Proc Natl Acad Sci USA 92:2889-1893
4. Qiu P, Ziegelhoffer PR, Yang NS (1996) Gene gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization. Gene Ther 3:262-268
5. Rakhmilevich AL, Turner J, Ford MJ, McCabe D, Sun WH, Sondel PM, Grota K, Yang NS (1996) Gene gunmediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. Proc Natl Acad Sci USA 93:6291
6. Cheng L, Ziegelhoffer PR, Yang NS (1993) In vivo promotor activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc Natl Acad Sci USA 90:4455-44559
7. Novakovik S, Knezevik M, Golouh R, Jezerzek B (1999) Transfection of mammalian cells by the methods of receptor mediated gene transfer and particle bombardment. J Exp Clin Cancer Res 18:531-6
8. Addison CL, Bramson JL, Hitt MM, Muller WJ, Gauldie J, Graham FL (1998) Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL12 results in enhanced frequency of regression of injected and untreated distal tumors. Gene Ther 5:1400
9. Albertini MR, Emler CA, Schell K, Tans KJ, King DM, Sheehy MJ (1996) Dual expression of human leukocyte antigen molecules and the B7.1 costimulatory molecule (CD80) on human melanoma cells after particle-mediated gene transfer. Cancer Gene Ther 3:192
10. Carr-Brendel V, Markovic D, Smith M, Tayler-Papadimitriou J, Cohen EP (1999) Immunity to breast cancer in mice immunized with X-irradiated breast cancer cells modified to secrete IL-12. J Immunother 22:415-422
11. Clary MB, Coveney EC, Blazer DG, Philip R, Lyerly HK (1996) Active immunotherapy of pancreatic cancer with tumor cells genetically engineered to secrete multiple cytokines. Surgery 120:174
12. Nemunaitis J, Bohart C, Fong T, Meyer W, Edelmann G, Paulson RS, Orr D, Jain V, O'Brien J, Kuhn J, Kowal KJ, Burkeholder S, Bruce J, Ognoskie N, Wynne D, Martineau D, Ando D (1998) Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanoma. Cancer Gene Ther 5:292-300
13. Rees RC, Mian S (1999) Selective MHC expression in tumors modulates adaptive and innate antitumor responses. Cancer Immunol Immunother 48:374
14. Rudy W, Guckel B, Siebels M, Lindauer M, Meuer SC, Moebius U (1997) Differential function of CD80- and CD86-transfected human melanoma cells in the presence of IL-12 and IFN-gamma. Int Immunol 9:853
15. Schreiber S, Kämpgen E, Wagner E, Pirkhammer D, Trcka J, Korschan H, Lindemann A, Dorffner R, Kittler H, Kastelitz F, Küpcü Z, Sinski A, Zatloukal K, Buschle M, Schmidt W, Birnstiel M, Kempe RE, Voigt T, Weber HA, Pehamberger H, Mertelsmann R, Bröcker EB, Wolff K, Stingl G (1999) Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2-transfected cancer cells: outcome of a phase I study. Hum Gene Ther 10:983
16. Nagai H, Hara I, Horikawa T, Fujii M, Kurimoto M, Kamidono S, Ichihasshi M (2000) Antitumor effects on mouse melanoma elicited by local secretion of interleukin-12 and their enhancement by treatment with interleukin-18. Cancer Invest 18:206
17. Zitvogel L, Robbins PD, Storkus WJ, Clarke MR, Maeurer MJ, Campbell RL, Davis CG, Tahara H, Schreiber RD, Lotze MT (1996) Interleukin-12 and B7.1 co-stimulation cooperate in the induction of antitumor immunity and therapy of established tumors. Eur J Immunol 26:1335
18. Thomas GR, Chen Z, Enamorado I, Bancroft C, Van Waes C (2000) IL-12 and IL-2-induced tumor regression in a new murine medel of oral squamouscell carcinoma is promoted by expression of the CD80 co-stimulatory molecule and IFN-gamma. Int J Cancer 86:368
19. Hiura M, Hashimura T, Watanabe Y, Kuribayashi K, Yoshida O (1994) Induction of specific anti-tumour immunity by interferon-γ gene-transferred murine bladder carcinoma MBT-2. Folia Biol 40:49-61
20. Katsanis E, Xu Z, Bausero MA, Dancisak BB, Gorden KB, Davis G, Gray GS, Orchard PJ, Blazar BR (1995) B7-1 Expression decreases tumorigenicity and induces partial systemic immunity to murine neuroblastoma deficient in major histocompatibility complex and costimulatory molecules. Cancer Gene Ther 2:39-46
21. +-matched situation. Cancer Gene Ther 6:282-288
22. Sun Y, Jurgovsky K, Moller P, Alijagic S, Dorbic T, Georgieva J, Wittig B, Schadendorf D (1998) Vaccination with IL-12 gene-modified autologus melanoma cells: clinical results and a first clinical phase I study. Gene Ther 5:481
23. Wang C, Quevedo ME, Lannutti BJ, Gordon KB, Guo D, Sun W, Paller AS (1999) In vivo gene therapy with interleukin-12 inhibt primary vascular tumor growth and induces apoptosis in a mouse model. J Invest Dermatol 122:775
24. Kraus K (2002) Der Partikel-vermittelte Gentransfer einer Kombination der Gene für Interleukin 12, Interleukin 2, Interferon γ und B7-1 zur Therapie Solider Maligner Tumore am Modell des murinen B16-Melanoms. Thesis, Leipzig University
25. Decken K, Köhler G, Palmer-Lehmann K, Wunderlich A, Mattner F, Magram, Gately MK, Alber G (1998) Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect Immun 66:4994-5000